Repro-Med Systems Inc. (REPR) insider have most recently took part in a trading activity. On Nov 28, 2017 Manko Joseph M. Jr., Director, 10% Owner bought 222,710 shares having total worth of $178,168 at the price of $0.8 per share, following the transaction a total of 6,399,779 shares owned by Manko Joseph M. Jr.. Before this latest buy, Manko Joseph M. Jr. purchased REPR at 12 other times during the past twelve months, for a total investment of $389,864 at an average of $0.45 per share.
The stock has experienced a total of 2 insider trades in the past three months. These trades include 2 buy trades. Furthermore, over the past 12 months , the stock was traded 15 times by insiders. In 3 of these trades, the insider was a seller while an employee of the company was the buyer in 12 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Repro-Med Systems Inc. (REPR) traded down 3.61% on Nov 27, 2017, hitting $0.8. 85,645 shares of the company’s stock traded hands. Repro-Med Systems Inc. has a 52 week low of $0.29 and a 52 week high of $0.83. The company’s market cap is $0 million.
Repro-Med Systems, Inc was incorporated in the State of New York in March of 1980. The Company designs, manufactures and markets proprietary medical devices mainly for emergency medical applications and ambulatory infusion therapy. These products are regulated by the FDA. Its development and marketing focus are concentrated on the RES-Q-VAC(R) and the FREEDOM60(R) products. The FREEDOM60 uses an innovative ‘engine’ to create a constant pressure drive system. FREEDOM60(R) uses rate-controlled tubing with standard slide clamp and luer-lock connector on the patient end. Proprietary technology Employed in the FREEDOM60 uses constant pressure to administer drugs. FREEDOM60 avoids an important problem faced by electronic pumps currently on the market which Employ constant flow mechanisms that result in potentially dangerous, high pressures placed on indwelling catheters or under the skin. The Freedom60 Syringe Infusion Pump is designed for ambulatory medication infusions. The Company also designed and manufactured the Freedom60-FM, an enhanced version of the Freedom60 which contains an electronic flow monitor system that provides occlusion and end of infusion alarm. The Freedom60 use for Primary Immune Deficiency by injecting immune globulin under the skin as a subcutaneous administration continued to increase usage during the past year. This method has provided patients with improved quality of life with much fewer unpleasant side effects over the traditional intravenous route. The RES-Q-VAC(R) Emergency Airway Suction System is a lightweight, portable, hand-operated suction device that removes fluids from a patient’s airway by attaching the RES-Q-VAC(R) pump to various proprietary sterile and non-sterile single-use catheters sized for adult and pediatric suctioning. The Company has introduced new, updated features including the FSP filter, new pediatric connectors, new graduated canister, new adult catheters, and new convenient carry pouch. It is also available with a flexible, portable LED white light source, which is attached to the top of the canister system and provides illumination for the medical professional during nighttime or low light conditions. The Company offers its products directly to large national accounts and emergency medical device distributors, as well as to regional distributors in the hospital respiratory care market.
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018